IMLFF - InMed Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20186/30/20176/30/20166/30/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development1,927.137746.162378.871943.211
Selling General and Administrative3,367.6982,320.9221,336.651,423.355
Non Recurring----
Others----
Total Operating Expenses8,609.5444,473.5272,377.1714,290.449
Operating Income or Loss-8,609.544-4,473.527-2,377.171-4,290.449
Income from Continuing Operations
Total Other Income/Expenses Net88.624-0.322-0.032-2.188
Earnings Before Interest and Taxes-8,609.544-4,473.527-2,377.171-4,290.449
Interest Expense----
Income Before Tax-8,520.92-4,473.849-2,377.203-4,292.637
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-8,520.92-4,473.849-2,377.203-4,292.637
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,520.92-4,473.849-2,377.203-4,292.637
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,520.92-4,473.849-2,377.203-4,292.637